Edition:
India

People: Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

2.19USD
18 Jun 2019
Change (% chg)

$0.02 (+0.92%)
Prev Close
$2.17
Open
$2.21
Day's High
$2.21
Day's Low
$2.10
Volume
2,350
Avg. Vol
401,545
52-wk High
$9.19
52-wk Low
$1.56

Elefant, Dov 

Mr. Dov Elefant has served as our Chief Financial Officer of Celsus Therapeutics PLC since January 11, 2012. From March 2011 until January 2012, he was Chief Financial Officer of Althera Medical Ltd. and from March 2009 to February 2011 he performed consulting services to a number of companies. He was also the Corporate Controller, from March 2007 to February 2009 for Lev Pharmaceuticals (OTCBB:LEVP), which was acquired by ViroPharma in 2008, Controller and Vice President of Finance and Administration at EpiCept Corporation (NASDAQ:EPCT.PK) from December 1999 to March 2007, Assistant Controller at Tetragenex Pharmaceuticals from November 1998 to October 1999 and held other accounting and finance roles from March 1991 to October 1998. Mr. Elefant holds a B.S. in accounting from Yeshiva University.

Basic Compensation

Total Annual Compensation, USD 200,000
Restricted Stock Award, USD 20,188
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 220,188

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --